NPI Portal NPI Lookup & Verification

Type 2 · Organization ✓ Active NPI ✓ Valid NPI checksum Organization subpart

Bio-Medical Applications of Texas, Inc.

End-Stage Renal Disease (ESRD) Treatment Clinic/Center in Pasadena, TX · enumerated 2016 · authorized official Barry Blanton, Vice President.

Data current as of Jul 13, 2026 · sourced from CMS NPPES

National Provider Identifier

1497101463

Verified

See something wrong? Report a correction

Registry record

Entity type Organization (Type 2)
Legal business name Bio-Medical Applications of Texas, Inc.
Other name <Unavail>
Parent organization Fresenius Medical Care Holdings, Inc.
Practice address 1210 Southmore Ave, Pasadena, TX, 77502
Phone (713) 475-6617
Fax (713) 475-6664
Enumeration date May 10, 2016
Last updated in NPPES Oct 19, 2023

Taxonomy & classification

261QE0700X End-Stage Renal Disease (ESRD) Treatment Clinic/Center Ambulatory Health Care Facilities Primary

Authorized official

Name Barry Blanton
Title Vice President
Phone (781) 699-9000

What is an NPI number?

A National Provider Identifier (NPI) is a unique 10-digit number that CMS assigns to every U.S. healthcare provider and organization under HIPAA. Type 1 NPIs identify individual providers; Type 2 NPIs identify organizations. The NPI appears on insurance claims, prescriptions, and credentialing paperwork, and never changes, even if the provider moves or changes specialty.

Read the full guide → Validate an NPI →

Frequently asked questions

What type of organization is Bio-Medical Applications of Texas, Inc.?
Bio-Medical Applications of Texas, Inc. is registered in NPPES as a End-Stage Renal Disease (ESRD) Treatment Clinic/Center (its primary provider taxonomy).
What is a Type 2 NPI?
A Type 2 NPI identifies an organization (group practice, hospital, pharmacy, lab), while Type 1 NPIs identify individual providers. Organizations bill under their Type 2 NPI.

Providers at this address

Browse all →

Source: CMS NPPES (public data). Snapshot 2026-07-13. Provider record last updated 2023-10-19.